Outset Medical, Inc.(OM)— Stock Profile, AI Score & Financials

Healthcare · Nasdaq · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated 2026-06-30.

Outset Medical, Inc. (OM) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores OM at 18.5/100 on a 32-signal composite quality model, placing it at rank #2,805 of 2,960 stocks — the bottom half of the AI-ranked universe. Areas of concern include institutional flow (4.6) and balance sheet strength (8.3), which score below median versus the broader universe. Shareholder dilution risk is elevated at 13.4/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q2 2026), Outset Medical, Inc. reports quarterly revenue of $31.6M, net income of $-18.0M, an operating margin of -49.5%. Top institutional holders of OM by reported 13-F value include FMR, BML Capital Management, AQR CAPITAL MANAGEMENT, based on the most recent SEC filings. OM trades on the Nasdaq exchange and files with the SEC under CIK 1484612. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate OM daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Outset Medical, Inc. directly from SEC EDGAR.